Arnold Freedman
Professor of Medicine, Harvard Medical School · Mass General Brigham
Credentials: · · · ·
History
- Present
- 1979–1982
- 1971–1975
Research
New England Journal of Medicine · 1991 · 728 citations
The Journal of Experimental Medicine · 2001 · 719 citations
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
The Journal of Immunology · 1989 · 527 citations
74 papers
54 papers · 5 as a fellow
39 papers
38 papers · 3 as a fellow
37 papers
- PM
Peter Mauch
32 papers
31 papers · 3 as a fellow
29 papers · 3 as a fellow
Grants
- 2004–2007
CpG Plus Rituximab Therapy in Follicular Lymphoma
National Cancer Institute · R21
Contact PI · $567.3K · Dana-Farber Cancer Inst
- 2002–2005
Etanercept Therapy in Follicular Lymphoma
National Cancer Institute · R21
Contact PI · $569.4K · Dana-Farber Cancer Inst
- 1999–2002
Integrin Signaling in Acute Lymphoblastic Leukemia
National Cancer Institute · R01
Contact PI · $499.8K · Dana-Farber Cancer Inst
- 1997–2002
Development of Novel Therapeutic Strategies in Human Leukemias
National Cancer Institute · P01
Project lead · $902K · Dana-Farber Cancer Inst
Clinical trials
- 2004–2009
Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
- 2004
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
Site PI · Unknown · Phase 2
Xcyte Therapies